Dimenhydrinate and Pericardial effusion - a phase IV clinical study of FDA data


Pericardial effusion is found among people who take Dimenhydrinate, especially for people who are female, 40-49 old.

The phase IV clinical study analyzes which people take Dimenhydrinate and have Pericardial effusion. It is created by eHealthMe based on reports of 4,618 people who have side effects when taking Dimenhydrinate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 12, 2022

4,618 people reported to have side effects when taking Dimenhydrinate.
Among them, 7 people (0.15%) have Pericardial effusion.

What is Dimenhydrinate?

Dimenhydrinate has active ingredients of dimenhydrinate. It is often used in nausea. eHealthMe is studying from 3,534 Dimenhydrinate users for its effectiveness, alternative drugs and more.

What is Pericardial effusion?

Pericardial effusion (fluid around the heart) is found to be associated with 1,882 drugs and 1,321 conditions by eHealthMe.

Number of Dimenhydrinate and Pericardial effusion reports submitted per year:

Could Dimenhydrinate cause Pericardial effusion?

Gender of people who have Pericardial effusion when taking Dimenhydrinate *:

  • female: 71.43 %
  • male: 28.57 %

Age of people who have Pericardial effusion when taking Dimenhydrinate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 14.29 %
  • 40-49: 57.14 %
  • 50-59: 14.29 %
  • 60+: 14.29 %

Common drugs people take besides Dimenhydrinate *:

  1. Vancomycin: 5 people, 71.43%
  2. Xanax: 4 people, 57.14%
  3. Morphine Sulfate: 4 people, 57.14%
  4. Benadryl: 4 people, 57.14%
  5. Clonazepam: 4 people, 57.14%
  6. Cyclosporine: 4 people, 57.14%
  7. Demerol: 4 people, 57.14%
  8. Famotidine: 4 people, 57.14%
  9. Flagyl: 4 people, 57.14%
  10. Heparin: 4 people, 57.14%

Common side effects people have besides Pericardial effusion *:

  1. Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 4 people, 57.14%
  2. Blood Lactate Dehydrogenase Increased: 4 people, 57.14%
  3. Febrile Neutropenia (fever with reduced white blood cells): 4 people, 57.14%
  4. Pleural Effusion (water on the lungs): 4 people, 57.14%
  5. Engraftment Syndrome (inflammatory condition during neutrophil recovery after hematopoietic stem cell transplantation): 4 people, 57.14%
  6. Infection: 3 people, 42.86%
  7. Respiratory Distress (difficulty in breathing): 3 people, 42.86%
  8. Lung Consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces): 2 people, 28.57%
  9. Computerised Tomogram Abnormal: 1 person, 14.29%
  10. Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 1 person, 14.29%

Common conditions people have *:

  1. Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 1 person, 14.29%
  2. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 1 person, 14.29%
  3. Adjustment Disorder With Depressed Mood: 1 person, 14.29%
  4. Anaemia (lack of blood): 1 person, 14.29%
  5. Device Related Infection: 1 person, 14.29%
  6. Folate Deficiency (lack of folic acid): 1 person, 14.29%
  7. High Blood Pressure: 1 person, 14.29%
  8. Hyperchlorhydria (gastric acid levels are higher in stomach): 1 person, 14.29%
  9. Hypercoagulation (increased tendency for clotting of the blood): 1 person, 14.29%
  10. Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Dimenhydrinate and have Pericardial effusion?

Check whether Pericardial effusion is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Pericardial effusion and when was it recovered:

Expand to all the drugs that have ingredients of dimenhydrinate:

Alternative drugs to, pros and cons of Dimenhydrinate:

Common Dimenhydrinate side effects:

Browse all side effects of Dimenhydrinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Pericardial effusion treatments and more:

COVID vaccines that are related to Pericardial effusion:

Common drugs associated with Pericardial effusion:

All the drugs that are associated with Pericardial effusion:

Common conditions associated with Pericardial effusion:

All the conditions that are associated with Pericardial effusion:

How the study uses the data?

The study uses data from the FDA. It is based on dimenhydrinate (the active ingredients of Dimenhydrinate) and Dimenhydrinate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: